Lakeland Industries (NASDAQ:LAKE) and Precision Therapeutics (NASDAQ:POAI) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability.
Risk & Volatility
Lakeland Industries has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, Precision Therapeutics has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500.
This is a summary of current ratings and recommmendations for Lakeland Industries and Precision Therapeutics, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Lakeland Industries presently has a consensus target price of $15.00, indicating a potential upside of 32.86%. Given Lakeland Industries’ higher possible upside, equities research analysts clearly believe Lakeland Industries is more favorable than Precision Therapeutics.
Earnings and Valuation
This table compares Lakeland Industries and Precision Therapeutics’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Lakeland Industries||$99.01 million||0.91||$1.46 million||$0.41||27.54|
|Precision Therapeutics||$1.41 million||11.11||-$10.09 million||N/A||N/A|
Lakeland Industries has higher revenue and earnings than Precision Therapeutics.
Institutional & Insider Ownership
60.6% of Lakeland Industries shares are owned by institutional investors. Comparatively, 0.8% of Precision Therapeutics shares are owned by institutional investors. 6.4% of Lakeland Industries shares are owned by insiders. Comparatively, 16.5% of Precision Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
This table compares Lakeland Industries and Precision Therapeutics’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Lakeland Industries beats Precision Therapeutics on 8 of the 11 factors compared between the two stocks.
About Lakeland Industries
Lakeland Industries, Inc. manufactures and sells a range of safety garments and accessories for the industrial and public protective clothing market in the United States and internationally. It offers limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks; high-end chemical protective suits to provide protection from highly concentrated, and hazardous chemical and biological toxins; and firefighting and heat protective apparel to protect against fire, burns, and excessive heat. The company also provides reusable woven garments, including electrostatic dissipative apparel for electric and gas utilities; flame resistant Nomex/FR and FR cotton coveralls/pants/jackets used in petrochemical and refining operations; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves for use in rescue operations; and protective products, such as gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to North American safety and mill supply distributors through a customer service group, regional sales managers, and independent sales representatives. It serves end user industrial customers, such as integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plant, janitorial, pharmaceutical, mortuary, and high technology electronics manufacturer industries, as well as scientific and medical laboratories; and federal, state, and local governmental agencies and departments. The company was founded in 1982 and is headquartered in Ronkonkoma, New York.
About Precision Therapeutics
Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables. The company also provides contract research organization (CRO) that offers personalized medicine solutions for pharmaceutical, diagnostic, and biotech industries. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company markets and sells its STREAMWAY Fluid Waste Management system and procedure disposables to medical facilities through various direct sales force and independent distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was founded in 2002 and is based in Eagan, Minnesota.
Receive News & Ratings for Lakeland Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeland Industries and related companies with MarketBeat.com's FREE daily email newsletter.